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Introduction
Chronic disease such as cardiovascular disease 
and cancer are the leading causes of death worldwide. 
Recent studies indicate that over the past two decades 
the number of new cancer cases has increased. Currently, 
cancer is known as a major public health problem 
and as the second leading cause of death worldwide 
(Siegel et al., 2016, Oschman, 2011). Although the 
incidence rate of cancer in developed countries is 2-folds 
more than in developing countries, according to the 
International Agency for Research on Cancer (IARC) 
reports, cancer is recognized as the most important leading 
cause of death in developing countries (Torre et al., 2015). 
In Iran, based on the National Cancer Registry (NCR), 
cancer is reported as the third most common cause 
of death after coronary heart disease and accidents. 
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The mortality rate of cancer in Iran has been reported 
as 41 and 65 per 100,000 in men and women respectively 
(Mousavi et al., 2009).
Esophageal cancer (EC) is defined as one of the 
gastrointestinal malignancies with a very high morbidity 
and mortality rate and low survival probability. EC is the 
sixth most common cancer related to death and also is 
the eighth most prevalent cancer in the world (Alsop and 
Sharma, 2016, Domper Arnal et al., 2015). EC is classified 
into main histological types including squamous cell 
carcinoma and adenocarcinoma. Multiple epidemiological 
studies indicated that the incidence of esophageal 
squamous cell cancer is decreasing whereas the incidence 
of esophageal carcinoma is rapidly increasing. This type 
of EC affects more than 45000 people across the world 
(Blot et al., 1991, Zhang et al., 2012). The survival 
rate of EC varies extensively around the world. Some 
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of the highest rates of esophageal cancer worldwide 
are seen in the ‘central Asian esophageal cancer belt’. 
This region includes the countries of the Caspian littoral, 
the central Asian republics, Mongolia and north-western 
China (Islami et al., 2004). Also South Africa and some 
European countries such as France and Italy have the 
high incidence rates (Lu et al., 1999, Eslick, 2009). 
EC death rate was reduced in women between 1990 
and 2004, however, for males there has been no such 
decrease in the world (Jemal et al., 2008). The survival 
rate of esophageal cancer is poor. In the United 
States, the 5-year survival rate for people with EC has 
been reported as 18% (Siegel et al., 2016). In Iran, the 
esophageal cancer is the second and third common 
malignancy in males and females, respectively (Sadjadi 
et al., 2010). Most patients with EC have been identified 
as being from the North and Northeast regions of the 
country (Ghavamzadeh et al., 2001). Among 35,000 deaths 
reported due to cancer in Iran, 5800 cases were attributed 
to esophageal cancer (Sadjadi et al., 2005). However, 
limited studies have been done regarding the survival of 
patients with EC in Iran (Somi et al., 2008). Therefore, the 
survival analysis of patients with esophageal cancer is very 
important and appropriate statistical models can better 
introduce the important prognostic factors to improve the 
survival of patients.
In the last few decades, clinical researchers have 
achieved progress in the treatment of chronic diseases. 
These achievements have increased the proportion 
of cured patients from many types of cancers. In this 
circumstances, the population consists of two groups of 
cured (or long-term survivors) and non-cured. In such 
situation, routine survival analysis approaches such as Cox 
proportional hazard model does not perform well due to 
the high number of censorings at the end of the follow-up 
period, and disability in considering the possibility of 
long-term survivors. Since a proportion of individuals 
will survive, cure model can be an appropriate and useful 
method to estimate cure fraction (Sy and Taylor, 2000; 
Lambert et al., 2007; Farewell, 1986). In the Current study, 
a non-mixture cure fraction model is utilized to determine 
the effects of risk factors on the survival and cure fraction 
of patients with esophageal cancer.
Materials and Methods
This retrospective cohort study enrolled a total 
of 127 patients with esophageal cancer who lived in 
East-Azarbaijan Province and were registered in Iran 
Registration Cancer during 2009-2010. These patients were 
followed up for a period of 5 years from 2010 to 2015. Data 
were sourced mainly from the patient reports of hospitals 
and pathology laboratories. The socio-demographic and 
clinical data were obtained using structured questionnaire 
and the patients’ clinical records. Survival information 
was collected through telephone interviews with the 
patients and/or their family members who were at home 
at the time of the interview. The beginning of the study 
was assumed as the pathologic diagnosis of cancer. Death 
due to esophageal cancer was regarded as the failure and 
survival time was calculated as the time interval between 
the date of cancer diagnosis and date of death due to 
esophageal cancer (for those who died) and the date of 
the last follow up (for those who were alive).
The risk factors which were recorded in the patients’ 
clinical data and were assessed in this study were the age at 
diagnosis, gender, education, job, marital status, smoking 
habit, non-communicable disease (NCD) affected status, 
Esophagectomy surgery, radiotherapy and chemotherapy.
In addition, wealth index patients’ socioeconomic 
status (SES) was identified based on a checklist of 
economic characteristics such as household fuel 
consumption, residential facilities, personal family 
facilities, household appliances used by the family, the 
source of household income, and total monthly household 
income. Principle component factor analysis was applied 
to obtain the socioeconomic status (low level/ high level). 
The Varimax approach to factor axes rotation was used in 
this study to determine the factor loading. After the factors 
was interpreted, the ones which their variances were 
greater than one and had high loadings were retained. 
The extracted factor called SES was transformed into an 
ordinal variable using visual Binnig and divided into two 
interval cut points based on median of extracted factor. 
According to the questionnaire and the responses of 
variables as considered for wealth index, the cut points 
were labeled as low level and high level. 
Statistical analysis
Descriptive characteristics of the patients were 
expressed as the mean ± standard deviation (SD) and 
frequency (percentage) for continuous and categorical 
variables, respectively. The log-rank test was applied to 
assess the unadjusted effect of variables on the survival 
time. The stepwise variable selection was used to 
investigate the best subset of variables in which the best 
fit on Cox proportional hazards model could be achieved. 
According to the stepwise method, this subset was 
obtained based on the variables which they had p-values 
less than 0.2 and more than 0.1 in this study. Variance 
inflation factor (VIF) was used to check the presence of 
multicollinearity between the covariates. The best subset 
of variables which resulted from the Cox proportional 
hazards model were assessed in the non-mixture cure 
fraction fitting.
The Kaplan-Meier survival plot was used to reveal 
whether the plot reached zero with the current amount 
of follow up time. The plot contributed to finding the 
proportion of survival cases. In the case of high survival 
rate, Cox regression model will lead to bias estimates. 
Cure models allow us to investigate what risk factors are 
associated with survival of cured and uncured patients. 
These models are a composition of incidence, which 
demonstrate whether the event of interest could eventually 
be experienced and a latency part, which demonstrates 
whether the event will occur for those subjects who are 
more prone to the event. The mixture and non-mixture 
cure fraction models are two major forms of cure fraction 
models. Non-mixture cure model or bounded cumulative 
hazard model uses particular approaches to model the 
survival and cure fraction parts of the model (Lambert et 
al., 2007, Maetani and Gamel, 2013). 
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(95% CI: 13.46-20.52) and 10.06 (95% CI: 6.49-13.63) 
months respectively. The patients’ characteristics and 
Log-rank results are shown in Table 1.
The stepwise selection indicated that sex, 
Esophagectomy surgery, marital status, SES, and 
radiotherapy had the best fit on the Cox proportional 
hazards model while the presence of multicollinearity 
between covariates was considered based on the VIF 
values.
We checked the PH assumption in the Cox regression 
model and the assumption was rejected (p-value=0.035). 
Therefore the Cox proportional hazards model was not 
appropriate for the dataset. As shown in Figure 1, the 
Kaplan-Meier curve is stabled at the probability of almost 
0.11 (Standard Deviation=0.01,95% CI: 0.07-0.19) which 
implies that the population cure rate is 11 percent. 
Table 2 demonstrates the results of non-mixture 
cure fraction model results.  According to the 
In this model, a log-log link function was used and the 
survival function can be written as follows:
Sp (t)=exp(-θ*F (t));
where θ=exp(β/ X) and F(t) is expressed as the 
cumulative distribution function for the non-cured group 
(Sposto, 2002; Rahimzadeh et al., 2014; Lambert et al., 
2007). 
The results were presented as point estimate from 
non-mixture cure fraction model. The sign of point 
estimate in non-mixture cure fraction with log-log link 
function shows in which groups of variable the probability 
of cure is more than the other one. If the sign of point 
estimate is positives, the cure probability of baseline group 
is more than the other one and vice versa (Sposto, 2002). 
Moreover, the 95% confidence intervals for the estimated 
effect sizes were demonstrated as 95% CI. The statistical 
programming R software, version 3.4.2 was used to 
perform the models and the p-value<0.05 was considered 
statistically significant.
Results
Our study was performed on 127 esophageal cancer 
patients, 35-88 years old. The mean (± standard deviation) 
age was 66.92 (± 11.95) years old. A total of 113 (89%) 
cases experienced the death due to esophageal cancer 
and 14 (11%) were alive by the end of the study. 
One, three and five-year survival probabilities were 
0.44 (95% CI: 0.36-0.54), 0.2 (95% CI: 0.14-0.28), and 
0.13 (95% CI: 0.08-0.2) respectively. The survival time 
ranges were from 0.10 to 69.03 months. The mean and 
median survival time for the uncured group were 16.99 
Figure 1. The Kaplan-Meier Curve of Patients with 
Esophageal Cancer
Figure 2. Kaplan-Meier Survival Curves of Covariates which Had Significant Effect on Non-mixture Cure Fraction 
Model
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estimations, Females had more probability to cure of 
EC in comparison to males (Estimate= -0.99; 95% 
CI:-1.41,-0.58; p-value<0.001). Patients in low level SES 
had less probability to cure of EC in comparison to patients 
in high level SES (Estimate=0.39; 95% CI: 0.12,0.66; 
p-value=0.043). Those who didn’t do Esophagectomy 
surgery were less likely to be cured death (Estimate= 0.34; 
95% CI: 0.17,0.99; p-value= 0.005). Moreover, unmarried 
cases had less likelihood of cure (Estimate=0.58; 95%CI: 
0.11,1.05; p-value=0.015). In addition, the obtained cure 
fraction was estimated 5.11% from model which was 
reasonable compared to population cure rate.
Figure 2 shows the Kaplan-Meier survival graph of 
covariates which had a significant effect on non-mixture 
cure fraction model. Kaplan-Meier curves for gender, 
SES, Esophagectomy surgery, and marital status 
demonstrated that the probability of cure in the female sex, 
high level, surgery and the married group was more than 
that of the males , low level, no Esophagectomy surgery 
and unmarried group respectively. 
Discussion
Our study demonstrated that factors such as sex, 
socioeconomic status, Esophagectomy surgery and martial 
status can be determining risk factors for esophageal 
cancer. In our data, a high proportion of patients died 
before the end of the study and a relatively short survival 
time was observed. 
The results of our study showed that females 
have higher odds of cure than males. Assessing the 
association between gender and EC, lots of confounding 
Variable n (%) Death 113 (89%) Log-Rank Test
mean survival time SE* p-value
Age 0.384
     ≥50 113 (89) 101 (89.4) 16.52 1.89
     <50 14 (11) 12 (85.7) 19.71 5.02
Gender <0.001
     male 70 (55.1) 68 (97.1) 10.4 1.29
     female 57 (44.9) 45 (78.9) 24.45 3.27
Education 0.989
     illiterate 98 (77.2) 87 (88.8) 17.14 2.08
     literate 29 (22.8) 26 (89.7) 16.21 3.43
Marital Status 0.524
     married 86 (67.7) 35 (85.4) 16.96 1.98
     unmarried 41 (32.3) 78 (90.7) 16.56 3.55
Job Status 0.004
     unemployed 79 (62.2) 67 (84.8) 20.61 2.52
     employed 48 (37.8) 46 (95.8) 10.70 1.87
Smoking Habit 0.554
     yes 42 (33.1) 40 (95.2) 14.39 2.21
     no 85 (66.9) 73 (85.9) 18.07 2.40
NCD affected Status 0.503
     no 103 (81.1) 93 (90.3) 16.30 1.92
     yes 24 (18.9) 20 (83.3) 18.51 4.15
Esophagectomy Surgery <0.001
     yes 72 (56.7) 59 (81.9) 22.48 2.80
     no 55 (43.3) 54 (98.2) 9.49 1.28
Chemotherapy 0.528
     yes 55 (43.3) 51 (92.7) 16.80 2.10
     no 72 (56.7) 62 (86.1) 16.52 2.62
Radiotherapy 0.263
     yes 43 (33.9) 39 (90.7) 18.08 2.60
     no 84 (66.1) 74 (88.1) 16.22 2.31
SES 0.008
     high level 66 (52) 62 (93.9) 21.57 2.90
     low level 61 (48) 51 (83.6) 12.55 1.97
Table 1. The Esophageal Cancer Patients’ Characteristics and the Results of Log-rank
*, Standard Error
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variables interfere. Generally, women’s lifestyle is 
less correlated with smoking habits and tobacco use, 
alcohol consumption, and other health risk behaviors. 
Melhado et al., (2010) investigated the changing face of 
esophageal cancer and showed that women are at a lower 
risk of EC. Bohanes et al., (2012) assessed the difference 
between the genders regarding the survival after positive 
diagnosis of esophageal cancer. They revealed that men 
have shorter survival rates in both metastatic and loco-
regional esophageal cancer. The difference between the 
genders survival time was justified due to the differences 
in hormones and women going through menopause. The 
same question was addressed by Mathieu et al., 2012) 
and it was observed that higher estrogen levels protect 
women against this cancer. It was revealed that the same 
behavior between the two genders happen after menopause 
among women.
In line with the expectations, a higher level of 
socioeconomic status was directly associated with 
the longer survival time of EC. Socioeconomic status 
is an accelerator of shorter survival time for various 
types of diseases including EC. The preparation of 
many cancer-related facilities including chemotherapy, 
hormone therapy, Esophagectomy surgery and other 
potential treatments is not straightforward for low-income 
patients and those with lower levels of socioeconomic 
status. In other words, the adverse outcomes of esophageal 
cancer are strongly associated with the negative 
consequences followed by the low socioeconomic status 
of the patients. Louwman et al., (2010) evaluated the 
frequency and prevalence of life-shortening factors for 
several cancers such as esophageal cancer among low 
socioeconomic status patients. Their study showed that 
the risk of suffering from another serious disease among 
cancer patients with low SES was 1.5 times greater than 
those with high SES levels. Tran et al., (2017) assessed 
the impact of sex, race, socioeconomic status, and 
treatment on the survival of esophageal cancer patients. 
They found that low SES can affect the likelihood of 
receiving Esophagectomy surgery which then results in 
shorter survival time. Relatedly, Dar et al., (2013) also 
demonstrated a negative relationship between the risk of 
esophageal squamous cell carcinoma and SES. 
Our study also showed that Esophagectomy surgery 
is an effective factor for improving the survival time 
of patient’s with esophageal cancer. Esophagectomy 
surgery is known as one of the best potential tools for the 
management of esophageal cancer. The positive and more 
efficient effect of Esophagectomy surgery can be observed 
in the early stages of cancer. In contrast, the other options 
such as chemotherapy and radiation therapy are suggested 
for later-stages. The outcomes after Esophagectomy 
surgery were investigated by D’Amico and it was shown 
that a combination of chemotherapy and Esophagectomy 
surgery results in a longer survival time for patients with 
EC (D’Amico, 2007). Lagergen et al., (2007) suggested 
the quality of life factors after Esophagectomy surgery as 
treatment for esophageal cancer. They exposed that the 
combination of Esophagectomy surgery and improved 
quality of life can extend the survival time of EC patients 
for at least 3 years.
Identifying any progress in cancer therapy depends 
on monitoring the trends of patients’ survival over 
time (Baghestani et al., 2015). The valuable measure 
of care for patients and clinician is the time from 
diagnosis of the disease until symptom occurrence 
(Andersson et al., 2011). In the recent years, the therapy for 
various types of cancers has been improved significantly. 
Therefore, the proportion of patients who are not susceptible 
to the occurrence of the study event (cure fraction) has 
increased (Asano et al., 2014). Furthermore, most 
of the cure rate models have been applied to cancer 
cases (Ortega et al., 2008). Since some cancer-related 
subjects may have long-term survival, cure rate models 
can be an appropriate method to characterize and study 
the patients’ survival (Akhlaghi et al., 2013). Mixture and 
Variable Estimate SE 95% CI** p.value***
lower upper
Gender
     Male *
     Female -0.99 0.21 -1.41 -0.58 <0.001
SES
     High level *
     Low level 0.39 0.14 0.12 0.66 0.043
Esophagectomy Surgery
     Yes *
     No 0.58 0.21 0.17 0.99 0.005
Radiotherapy
     Yes *
     No 0.34 0.20 -0.06 0.73 0.093
Martial status
     Married *
     Unmarried 0.58 0.24 0.11 1.05 0.015
Table 2. Estimation Based on Non-mixture Cure Fraction Model with Log (-log) Link Function 
*, Stands for a baseline group;**, 95% confidence interval;***, Significant at the 5% level
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non-mixture are two general forms of cure models and 
the use of each model depends on data (Baghestani et 
al., 2015). In the current study, non-mixture cure fraction 
model was used to estimate the effect size of potential risk 
factors that affect patients’ survival.
However, there are lots of other factors related to 
the esophageal cancer lifetime such as metastatic status, 
tumor size, and stage of disease and the certain type of 
esophageal cancer (adenocarcinoma and squamous). 
These prognostic factors were not assessed because of the 
lack of access to the medical records of patients and the 
unavailability of the data in the East-Azarbayjan cancer 
registry. 
In conclusion, although esophageal cancer is known 
as a fatal disease with a low survival rate,significant 
improvement of therapies for this cancer have been 
identified in the recent years. Moreover, using appropriate 
survival analysis can help the clinicians and researchers 
to determine potential risk factors which can affect 
the survival of patients who are not susceptible to EC. 
In this study, gender, SES, Esophagectomy surgery, 
and marital status are determined as risk factors that 
affect both survival and cure fraction of patients with 
EC. Non- mixture cure fraction provides more accurate 
and more reliable insight into long-term advantages of 
EC therapy compared to standard classic survival analysis 
alternatives.
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